methyl cinnamate has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; E, L; Hu, Y; Li, W; Yao, J; Zhou, X | 1 |
| Aragão, KS; Brito, TS; Cosker, F; Lahlou, S; Lima, FJ; Magalhães, PJ; Ribeiro-Filho, HV; Santos, AA; Silva, CM; Souza, MH | 1 |
2 other study(ies) available for methyl cinnamate and Colitis
| Article | Year |
|---|---|
Methyl cinnamate protects against dextran sulfate sodium-induced colitis in mice by inhibiting the MAPK signaling pathway.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Mice; Mice, Inbred C57BL; Signal Transduction | 2023 |
Antispasmodic and myorelaxant effects of the flavoring agent methyl cinnamate in gut: potential inhibition of tyrosine kinase.
Topics: Acetic Acid; Animals; Calcium; Calcium Channel Blockers; Carbachol; Cinnamates; Colitis; Colon; Duodenum; Flavoring Agents; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Parasympatholytics; Potassium Chloride; Protein-Tyrosine Kinases; Rats, Wistar; Stomach | 2014 |